First Trust Advisors LP bought a new position in shares of Quidel Co. (NASDAQ:QDEL) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 65,208 shares of the company’s stock, valued at approximately $2,827,000. First Trust Advisors LP owned about 0.19% of Quidel as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in QDEL. California Public Employees Retirement System raised its holdings in Quidel by 2.9% during the fourth quarter. California Public Employees Retirement System now owns 59,799 shares of the company’s stock worth $2,592,000 after acquiring an additional 1,696 shares in the last quarter. Teacher Retirement System of Texas acquired a new position in shares of Quidel in the fourth quarter valued at approximately $421,000. Chicago Equity Partners LLC grew its position in shares of Quidel by 348.9% in the fourth quarter. Chicago Equity Partners LLC now owns 44,890 shares of the company’s stock valued at $1,946,000 after purchasing an additional 34,890 shares during the last quarter. Mesirow Financial Investment Management Equity Management acquired a new position in shares of Quidel in the fourth quarter valued at approximately $16,097,000. Finally, Schwab Charles Investment Management Inc. grew its position in shares of Quidel by 6.0% in the fourth quarter. Schwab Charles Investment Management Inc. now owns 192,647 shares of the company’s stock valued at $8,352,000 after purchasing an additional 10,843 shares during the last quarter. 93.28% of the stock is owned by institutional investors and hedge funds.
Shares of Quidel Co. (NASDAQ QDEL) opened at $50.32 on Friday. The stock has a market cap of $1,741.93, a PE ratio of -209.67, a price-to-earnings-growth ratio of 1.64 and a beta of 1.03. The company has a debt-to-equity ratio of 1.66, a quick ratio of 2.06 and a current ratio of 2.58. Quidel Co. has a 1 year low of $21.22 and a 1 year high of $50.68.
Quidel (NASDAQ:QDEL) last issued its quarterly earnings data on Wednesday, February 21st. The company reported $0.56 EPS for the quarter, beating the consensus estimate of ($0.14) by $0.70. Quidel had a negative net margin of 2.94% and a negative return on equity of 3.02%. The firm had revenue of $114.90 million during the quarter, compared to the consensus estimate of $115.06 million. During the same period in the prior year, the firm posted $0.17 earnings per share. The company’s quarterly revenue was up 117.6% compared to the same quarter last year. equities research analysts anticipate that Quidel Co. will post 1.22 EPS for the current year.
In other Quidel news, Director Jack W. Schuler sold 4,000 shares of the company’s stock in a transaction dated Friday, January 5th. The shares were sold at an average price of $47.02, for a total value of $188,080.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Ratan S. Borkar sold 29,880 shares of the company’s stock in a transaction dated Thursday, January 4th. The stock was sold at an average price of $45.15, for a total transaction of $1,349,082.00. Following the completion of the sale, the senior vice president now owns 20,253 shares in the company, valued at approximately $914,422.95. The disclosure for this sale can be found here. In the last 90 days, insiders sold 165,880 shares of company stock worth $7,463,122. Corporate insiders own 22.00% of the company’s stock.
QDEL has been the topic of a number of analyst reports. CL King raised Quidel from a “neutral” rating to a “buy” rating and set a $52.00 price target on the stock in a research report on Thursday, January 4th. Barclays increased their price target on Quidel from $50.00 to $60.00 and gave the company an “overweight” rating in a research note on Monday, January 22nd. Piper Jaffray Companies reiterated a “buy” rating and issued a $50.00 price target on shares of Quidel in a research note on Thursday, December 14th. Zacks Investment Research downgraded Quidel from a “hold” rating to a “strong sell” rating in a research note on Thursday, December 28th. Finally, BidaskClub upgraded Quidel from a “sell” rating to a “hold” rating in a research note on Saturday, December 2nd. One investment analyst has rated the stock with a hold rating, six have given a buy rating and two have given a strong buy rating to the stock. Quidel has a consensus rating of “Buy” and a consensus target price of $53.50.
ILLEGAL ACTIVITY NOTICE: “65,208 Shares in Quidel Co. (QDEL) Purchased by First Trust Advisors LP” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this article on another website, it was illegally copied and republished in violation of international copyright and trademark laws. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/03/23/first-trust-advisors-lp-invests-2-83-million-in-quidel-co-qdel-stock.html.
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.
Receive News & Ratings for Quidel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel and related companies with MarketBeat.com's FREE daily email newsletter.